SCHEMBL4458309

SCHEMBL4458309

O=P(Oc1ccccc1)(OC1CCCCC1)OC1CCCCC1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
RAB9A P51151 1/20 0.42
SRC P12931 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
LMNA P02545 1/20 0.41
DPP7 Q9UHL4 2/20 0.39
KDM4E B2RXH2 1/20 0.38
ACHE P22303 1/20 0.38
METAP2 P50579 2/20 0.37
METAP1 P53582 1/20 0.37
DPP4 P27487 1/20 0.37
DPP8 Q6V1X1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3472688 0.96 ALDH1A1 (0.42) ALDH1A1RAB9ASRCTDP1L3MBTL1
SCHEMBL28611135 0.95 SRC (0.44) ALDH1A1RAB9ASRCTDP1L3MBTL1
SCHEMBL29273766 0.91 SRC (0.44) ALDH1A1RAB9ASRCTDP1L3MBTL1
SCHEMBL4462734 0.91 SRC (0.47) SRCTDP1L3MBTL1MEN1KMT2A
SCHEMBL22171417 0.88 CYP3A4 (0.51) ALDH1A1RAB9AL3MBTL1MEN1KMT2A
SCHEMBL3475395 0.87 SRC (0.47) SRCTDP1L3MBTL1MEN1KMT2A
SCHEMBL5859474 0.86 PKM (0.36) ALDH1A1RAB9ASRCTDP1L3MBTL1
SCHEMBL5859623 0.86 SRC (0.42) ALDH1A1RAB9ASRCTDP1L3MBTL1
SCHEMBL13865267 0.84 DPP4 (0.36) ALDH1A1RAB9ASRCTDP1L3MBTL1
SCHEMBL7772943 0.84 NPSR1 (0.42) SRCL3MBTL1MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015372-A1 Organophosphorous Compounds and Uses Thereof JAL THERAPEUTICS LLC (US) 2026-01-15 US claimed
WO-2024020507-A2 ORGANOPHOSPHOROUS COMPOUNDS AND USES THEREOF JAL THERAPEUTICS, LLC (US) 2024-01-25 WO claimed
US-20260015372-A1 Organophosphorous Compounds and Uses Thereof JAL THERAPEUTICS LLC (US) 2026-01-15 US disclosed
WO-2024020507-A2 ORGANOPHOSPHOROUS COMPOUNDS AND USES THEREOF JAL THERAPEUTICS, LLC (US) 2024-01-25 WO disclosed
EP-3279406-A1 FLAME-RETARDANT FLOOR MATERIAL AND METHOD FOR MANUFACTURING SAME LG Hausys, Ltd. (KR) 2018-02-07 EP disclosed
US-20170043558-A1 A FLAME RETARDANT FLOORING MATERIAL AND METHOD OF MANUFACTURING THE SAME LG HAUSYS, LTD. (KR) 2017-02-16 US disclosed
EP-1809474-B1 FIRE RESISTANT POLYMER SHEETS SOLUTIA INC (US) 2016-05-11 EP disclosed
US-7612148-B2 Hydrogenation catalyst composition and method for hydrogenation of conjugated diene polymer TSRC CORPORATION (TW) 2009-11-03 US disclosed
US-7399525-B2 Between two glass panes a multilayer interlayer conposed of a fluoropolymer sheet (hexafluoropropylene-tetrafluoroethylene-vinylidene fluoro terpolymer) having a thickness of 0.1 to 1.5 millimeters and a polyvinyl butyral polymer sheet; fire resistance SOLUTIA INCORPORATED (US) 2008-07-15 US disclosed
US-20080146733-A1 Hydrogenation catalyst composition and method for hydrogenation of conjugated diene polymer TSRC CORPORATION (TW) 2008-06-19 US disclosed
US-7279516-B2 Polymer sheets comprising higher order phosphate esters SOLUTIA INCORPORATED (US) 2007-10-09 US disclosed
EP-1809474-A1 FIRE RESISTANT POLYMER SHEETS Solutia Inc. (US) 2007-07-25 EP disclosed
US-7238427-B2 Fire resistant polymer sheets SOLUTIA INCORPORATED (US) 2007-07-03 US disclosed
WO-2006098777-A1 POLYMER SHEETS COMPRISING HIGHER ORDER PHOSPHATE ESTERS SOLUTIA INCORPORATED (US) 2006-09-21 WO disclosed
WO-2006050218-A1 POLYMER SHEETS COMPRISING A FLUOROPOLYMER SOLUTIA INCORPORATED (US) 2006-05-11 WO disclosed
WO-2006050216-A1 FIRE RESISTANT POLYMER SHEETS SOLUTIA INCORPORATED (US) 2006-05-11 WO disclosed
US-20060093832-A1 Fire resistant polymer sheets SOLUTIA INC. 2006-05-04 US disclosed
US-20060094803-A1 Polymer sheets comprising higher order phosphate esters SOLUTIA, INC. 2006-05-04 US disclosed
US-20060093830-A1 Polymer sheets comprising a fluoropolymer SOLUTIA, INC. 2006-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015372-A1 Organophosphorous Compounds and Uses Thereof ACHE, BCHE, MUSK ALDH1A1 4365/4885RAB9A 1761/4885SRC 2279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.